SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-017608
Filing Date
2022-06-23
Accepted
2022-06-23 16:56:10
Documents
12
Period of Report
2022-06-23
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 form8k.htm   iXBRL 8-K 62192
  Complete submission text file 0001493152-22-017608.txt   239581

Data Files

Seq Description Document Type Size
2 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT sonn-20220623.xsd EX-101.SCH 2962
3 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT sonn-20220623_lab.xml EX-101.LAB 34916
4 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT sonn-20220623_pre.xml EX-101.PRE 22791
6 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 3790
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 221036122
SIC: 2834 Pharmaceutical Preparations